Best Science Medicine Podcast - BS without the BS

Episoder

• 
  Episode 625: Blood Pressure Measurement Technique: Meaningful mistakes or minor details? 23.07.2026 35min

  In episode 625, Mike K and James invite Danielle Perry and Tony Nickonchuk to the podcast to talk about the evidence around blood pressure measurement techniques. You might be surprised by what does and does not influence blood pressure measurements. Check out the podcast. Show Notes Tools For Practice Blood Pressure Measurement Technique: Meaningful mistakes […]
• 
  Episode 624: PCSK9 Inhibitors: Cardiovascular prevention panacea or pricey pokes? 17.07.2026 26min

  In episode 624, James and Mike K invite Tony Nickonchuk to go over all the new evidence we have for the PCSK9 inhibitors. First, we discuss whether or not the evidence addresses the issue of primary versus secondary prevention. We then give you all the numbers and the context you need to allow you to […]
• 
  Episode 623: Less than 140, 130, or 120? Counting down to the optimal systolic blood pressure target 08.06.2026 25min

  In episode 623, Jamie and James invite Samantha Moe back again to talk about the never-ending debate as to what is the target for systolic blood pressure. We look at the evidence and then try to put it into a reasonable context because at best the evidence is always nuanced. But at least you will […]
• 
  Episode 622: Bronchodilator with Benefits? Budesonide-formoterol rescue inhaler for asthma 30.05.2026 27min

  In episode 622, Jamie and James invite Émélie Braschi back again to talk about if we should be using inhalers that combine corticosteroids and beta-agonists as rescue inhalers. We go over the best available evidence and then try to put the findings into context. Show Notes Tools For Practice Bronchodilator with Benefits? Budesonide-formoterol rescue inhaler […]
• 
  Episode 621: Whole-Body MRI for Cancer Screening: Many findings, little benefit 27.04.2026 19min

  In episode 621, Tina, James and Mike K talk about the evidence around whole-body MRIs. We discuss how many abnormalities are found, how many cancers are actually found, and finally the lost opportunity costs. You need to know these numbers to talk to your patients about the value or lack thereof of doing this test. […]